DAYTON, OH
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)DAYTON CLINICAL ONCOLOGY PROGRAM INC, founded in 1983, is a small nonprofit in the Diseases & Disorders sector that reported $975K in total revenue in fiscal year 2024. Revenue decreased 5% compared to the prior year. Expenses of $1.1M exceeded revenue, resulting in a 17% operating deficit.
TO REDUCE CANCER INCIDENCE AND MORTALITY THROUGH IMPROVED TREATMENT AND PREVENTION BY OFFERING NATIONAL, STATE-OF-THE-ART CANCER RESEARCH TO LOCAL COMMUNITIES.
DAYTON CLINICAL ONCOLOGY PROGRAM, INCORPORATED IN 1983, WAS DESIGNATED ONE OF THE ORIGINAL NATIONAL CANCER INSTITUTE (NCI) GRANT-FUNDED COMMUNITY CLINICAL ONCOLOGY PROGRAMS. ITS MISSION IS TO PROVIDE...
DAYTON CLINICAL ONCOLOGY PROGRAM, INCORPORATED IN 1983, WAS DESIGNATED ONE OF THE ORIGINAL NATIONAL CANCER INSTITUTE (NCI) GRANT-FUNDED COMMUNITY CLINICAL ONCOLOGY PROGRAMS. ITS MISSION IS TO PROVIDE ACCESS TO STATE-OF-THE-ART NCI CLINICAL TRIALS TO COMMUNITIES THROUGHOUT OHIO AND EASTERN INDIANA. MEMBERSHIP WITHIN THE NCI NETWORK PROVIDES ACCESS TO PHASE II AND PHASE III TRIALS FOR NEWLY DIAGNOSED AS WELL AS ADVANCED CANCER PATIENTS, WITH OPTIONS FOR TREATMENT, SYMPTOM MANAGEMENT, CANCER CARE DELIVERY, AND DEMOGRAPHIC TRIALS. THE COLLABORATION BETWEEN DAYTON CLINICAL ONCOLOGY PROGRAM AND ITS CONSORTIUM MEMBERS OF EIGHT HOSPITALS, 48 PHYSICIANS REPRESENTING MEDICAL, SURGICAL AND RADIATION ONCOLOGY, AND HOSPITAL-BASED ONCOLOGY RESEARCH COORDINATORS IS WHAT MAKES THE PROGRAM SUCCESSFUL AND AVAILABLE FOR CANCER PATIENTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $974,625 | $1,029,621 | -0.1% |
| Expenses | $1,138,634 | $1,142,435 | 0.0% |
| Net Income | $-164,009 | $-112,814 | +0.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| HOWARD M GROSS | CHAIRPERSON | 1.50 |
Officer
Director
|
$25,000 | $0 | $25,000 |
| ROGER WOOD | VICE CHAIRPERSON | 0.30 |
Officer
Director
|
$0 | $0 | $0 |
| ALISHA REISS | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| MICHELLE KINNEY | PRESIDENT/CEO | 40.00 |
Officer
Director
|
$84,672 | $0 | $84,672 |
| ANDREA MOLINA | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| GILBERT PADULA | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| JULIE PRATT | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| AMY M MILLS | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| MARY ONTKO | INTERIM PRESIDENT/CEO | 40.00 |
Officer
|
$44,175 | $0 | $44,175 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $974,625 | $1,138,634 | $2,961,723 | $-164,009 |
| 2024 | $1,029,621 | $1,142,435 | $3,080,790 | $-112,814 |
| 2023 | $1,111,956 | $1,221,214 | $3,198,697 | $-109,258 |
| 2022 | $1,120,839 | $1,115,578 | $2,853,577 | $5,261 |
| 2021 | $1,286,734 | $1,043,661 | $3,051,449 | $243,073 |
| 2020 | $1,278,660 | $1,136,571 | $2,811,152 | $142,089 |
| 2019 | $1,092,868 | $1,161,169 | $2,640,538 | $-68,301 |
Compare DAYTON CLINICAL ONCOLOGY PROGRAM INC with other nonprofits in Ohio and across the country.